RELATIONSHIP BETWEEN PAIN CRISIS AND LIFE-THREATENING COMPLICATIONS IN SICKLE CELL DISEASE- A RETROSPECTIVE CLAIMS BASED STUDY

Author(s)

Bhor M1, Wang Y2, Xie L2, Halloway R1, Arcona S3, Paulose J1, Ogbomo A2, Shen Y2, Yuce H4, Shah N5
1Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 2STATinMED Research, Ann Arbor, MI, USA, 3Novartis Pharmaceuticals, East Hanover, NJ, USA, 4New York City College of Technology-CUNY and STATinMED Research, New York, NY, USA, 5Duke University School of Medicine, Durham, NC, USA

OBJECTIVES: To evaluate the relationship between pain crisis and life-threatening complications in sickle-cell disease (SCD) patients.

METHODS: A retrospective study was conducted using the Medicaid Analytic Extracts Database from 2009-2013. SCD patients were identified using ICD-9-CM diagnosis codes (282.41-282.42, 282.60-282.69) and first observed SCD diagnosis during the identification period was designated as index date. Patients were required to have continuous Medicaid enrollment for 6-month pre- (baseline) and 12-month post-index period and were followed until earliest occurrence of disenrollment, death, or study end. Patient characteristics, pain crisis, mortality and life-threatening complications were examined. Pain crisis was defined as inpatient stay with a diagnosis of SCD with crisis (ICD-9-CM: 282.42, 282.62, 282.64, 282.69). Cox regression was used to evaluate the relationship between pain crisis and life-threatening complications with pain crisis in the follow-up as a time-dependent covariate.

RESULTS: A total of 20,909 patients were included with a mean age of 17.9 (Standard Deviation=15.2]) years. 65.7% of the patients were black with an average Charlson Comorbidity Index of 0.4. The event rate of inpatient pain crisis (including multiple events per person) was 89.1 in 100 person-years and mortality was 0.5 in 100 person-years. Incidence rates of life-threatening complications in 100 person-years were: acute chest syndrome (5.6), stroke (2.0), pulmonary embolism (0.8), splenic sequestration (0.7), and pulmonary hypertension (0.7). Patients with follow-up pain crisis had higher risk for death (Hazard Ratio[HR]=1.6, 95% Confidence Interval [CI] [1.2, 2.0]) or life-threatening complications such as acute chest syndrome (HR=58.7, 95% CI [50.2, 68.6]), stroke (HR=2.3, 95% CI [1.9, 2.6]), pulmonary embolism (HR=2.8, 95% CI [2.2, 3.6]), splenic sequestration (HR=44.0, 95% CI [30.7, 63.1]) and pulmonary hypertension (HR=4.1, 95% CI [3.1, 5.4]) compared to patients without pain crisis.

CONCLUSIONS: SCD patients had substantial burden of complications, and patients with pain crises had higher risk of other life-threatening complications.

Conference/Value in Health Info

2018-05, ISPOR 2018, Baltimore, MD, USA

Value in Health, Vol. 21, S1 (May 2018)

Code

PSY9

Topic

Clinical Outcomes, Epidemiology & Public Health

Topic Subcategory

Relating Intermediate to Long-term Outcomes

Disease

Rare and Orphan Diseases, Systemic Disorders/Conditions

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×